Differential expression of Trypanosoma cruzi I associated with clinical forms of Chagas disease: Overexpression of oxidative stress proteins in acute patient isolate

Journal of Proteomics

Volumn 74, Issue 9, 2011, Pages 1673-1682

  Diaz M L ^a   Solari, A ^b   Gonzalez C I ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Acute Chagas disease; Chagas disease; Colombia; HSP70; Lipoamide dehydrogenase; Oxidative stress proteins; Trypanosoma cruzi group I; Tryparedoxin peroxidase

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; OXIDATIVE STRESS PROTEIN; PROTOZOAL PROTEIN; TRYPAREDOXIN PEROXIDASE; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; CHAGAS DISEASE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PARASITE ISOLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GENETIC VARIATION; LIFE CYCLE STAGES; OXIDATIVE STRESS; PROTEOMICS; PROTOZOAN PROTEINS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 80051673172     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.05.001     Document Type: Article

References (53)

1. Moncayo A., Silveira A.C. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009, 104:17-30.
2. Dumonteil E. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era. Infect Genet Evol 2009, 9:1075-1082.
3. Wilkinson S.R., Taylor M.C., Horn D., Kelly J.M., Cheeseman I. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci USA 2008, 105:5022-5027.
4. de Souza W. Cell biology of Trypanosoma cruzi. Int Rev Cytol 1984, 86:197-283.
5. Clayton C.E. Life without transcriptional control from fly to man and back again. EMBO J 2002, 21:1881-1888.
6. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001, 1:92-100.
7. Zafra G., Mantilla J.C., Valadares H.M., Macedo A.M., González C.I. Evidence of Trypanosoma cruzi II infection in Colombian chagasic patients. Parasitol Res 2008, 103:731-734.
8. Todeschini A.R., de Almeida E.G., Agrellos O.A., Jones C., Previato J.O., Mendoca-Previato L. α-N-acetylglucosamine- linked O-glycans of sialoglycoproteins (Tc- mucins) from Trypanosoma cruzi Colombiana strain. Mem Inst Oswaldo Cruz 2009, 104:270-274.
9. Torres O.A., Calzada J.E., Beraún Y., et al. Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population. Infect Genet Evol 2010, 10:682-685.
10. Vago A.R., Andrade L.O., Leite A.A. d'Avila Reis D, Macedo AM, Adad SJ Tostes Jr S, Moreira MCV, Brasileiro Filho G, Pena SDJ. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 2000, 156:1805-1809.
11. Mantilla J.C., Zafra G., Macedo A.M., González C.I. Mixed infection of Trypanosoma cruzi I and II in a Colombian cardiomyopathic patient. Hum Pathol 2010, 41:610-613.
12. Zingales B. Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Second Satellite Meeting. Mem Inst Oswaldo Cruz 2009, 104:1051-1054.
13. González C.I., Ortiz S., Solari A. Colombian Trypanosoma cruzi major genotypes circulating in patients: minicircle homologies by cross-hybridization analysis. Int J Parasitol 2010, 40:1685-1692.
14. Burleigh B., Andrews N. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu Rev Microbiol 1995, 49:175-200.
15. Flohé l, Hecht H.J., Steinert P. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 1999, 27:966-984.
16. Piñeyro M.D., Parodi-Talice A., Arcari T., Robello C. Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?. Gene 2008, 408:45-50.
17. Goldberg S.S., Chiari E. Growth and isolation of single colonies of Trypanosoma cruzi on solid medium. J Parasitol 1980, 66:677-679.
18. Velazco C., Puentes F., Moreno A., Patarroyo M.E., Puerta C. Adaptación de la cepa Munantá de Trypanosoma cruzi al cultivo in vitro en células Vero. Universitas Scientiarum 1997, 4:83-94.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
20. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
21. Naranjo V., Villar M., Martín-Hernando M.P., et al. Proteomic and transcriptomic analyses of differential stress/inflammatory responses in mandibular lymph nodes and oropharyngeal tonsils of European wild boars naturally infected with Mycobacterium bovis. Proteomics 2007, 7:220-231.
22. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
23. Macedo A.M., Pena S.D. Genetic Variability of Trypanosoma cruzi: Implications for the Pathogenesis of Chagas Disease. Parasitol Today 1998, 14:119-124.
24. D'Avila D.A., Macedo A.M., Valadares H.M., et al. Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients. J Clin Microbiol 2009, 47:1718-1725.
25. Paba J., Santana J.M., Teixeira A.R., Fontes W., Sousa M.V., Ricart C.A. Proteomic analysis of the human pathogen Trypanosoma cruzi. Proteomics 2004, 4:1052-1059.
26. Nakayasu E.S., Gaynor M.R., Sobreira T.J., Ross J.A., Almeida I.C. Phosphoproteomic analysis of the human pathogen Trypanosoma cruzi at the epimastigote stage. Proteomics 2009, 9:3489-3506.
27. Paba J., Ricart C.A., Fontes W., et al. Proteomic analysis of Trypanosoma cruzi developmental stages using isotope-coded affinity tag reagents. J Proteom Res 2004, 3:517-524.
28. Krauth-Siegel R.L., Comini M.A. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochem Biophys Acta 2008, 1780:1236-1248.
29. Nogueira F.B., Ruiz J.C., Robello C., Romanha A.J., Murta S.M.F. Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Parasitol Res 2009, 104:835-844.
30. Piacenza L., Peluffo G., Alvarez M.N., Kelly J.M., Wilkinson S.R., Radi R. Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 2008, 410:359-368.
31. Piacenza L. Enzymes of the antioxidants network as novel determiners of Trypanosoma cruzi virulence. Int J Parasitol 2009, 39:1455-1464.
32. Gutierrez J. Trypanosoma cruzi Dihydrolipoamide Dehydrogenase as target for phenothiazine cationic radicals: Effect of antioxidants. Curr Drug Targets 2006, 7:1155-1179.
33. Schöneck R., Billaut-Mulot O., Numrich P., Ouaissi M.A., Krauth-Siegel R.L. Cloning, sequencing and functional expression of dihydrolipoamide dehydrogenase from the human pathogen Trypanosoma cruzi. Eur J Biochem 1997, 243:739-747.
34. Sobrado V.R., Montemartini-Kalisz M., Kalisz H.M., De La Fuente M.C., Hecht H.J., Nowicki C. Involvement of conserved asparagine and arginine residues from the N-terminal region in the catalytic mechanism of rat liver and Trypanosoma cruzi tyrosine aminotransferases. Protein Sci 2003, 12:1039-1050.
35. De-Eknamkul W., Ellis B.E. Purification and characterization of tyrosine aminotransferase activities from Anchusa officinalis cell cultures. Arch Biochem Biophys 1987, 257:430-438.
36. Berger B.J., Dai W.W., Wilson J. Methionine formation from a-ketomethiobutyrate in the trypanosomatid Crithidia fasciculata. FEMS Microbiol Lett 1998, 165:305-312.
37. Pavlovic D., Uzunova P., Galabova T., et al. Polyamines as modulators of lipoperoxidation. Gen Physiol Biophys 1992, 11:203-211.
38. Hernandez S.M., Sanchez M.S., Schwarcz M.N. Polyamines as a defense mechanism against lipoperoxidation in Trypanosoma cruzi. Acta Trop 2006, 98:94-102.
39. Tabor C.W., Tabor H. Polyamines in microorganism. Microbiol Rev 1985, 49:81-99.
40. Fairlamb A.H., Cerami A. Metabolism and functions of trypanothione in the kinetoplastida. Annu Rev Microbiol 1992, 46:695-729.
41. Nogoceke E., Gommel D.U., Kiess M., Kalisz H.M., Flohé L. A unique cascade of oxidoreductases catalyses trypanothione mediated peroxide metabolism in Crithidia fasciculata. Biol Chem 1997, 378:827-836.
42. Rego J.V., Murta S.M., Nirdé P., Nogueira F.B., de Andrade H.M., Romanha A.J. Trypanosoma cruzi: Characterization of the gene encoding tyrosine aminotransferase in beznidazole - resistant and susceptible populations. Exp Parasitol 2008, 118:111-117.
43. Atwood J.A., Weatherly D.B., Minning T.A., et al. TheTrypanosoma cruzi Proteome. Science 2005, 309:473-476.
44. Cuevas I.C., Cazzulo J.J., Sanchez D.O. Gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infect Immun 2003, 71:5739-5749.
45. Grandgenett P.M., Coughlin B.C., Kirchhoff L.V., Donelson J.E. Differential expression of GP63 genes in Trypanosoma cruzi. Mol Biochem Parasitol 2000, 110:409-415.
46. Kulkarni M.M., Olson C.L., Engman D.M., McGwire B.S. Trypanosoma cruzi GP63 Proteins Undergo Stage Specific Differential Posttranslational Modification and Are Important for Host Cell Infection. Infect Immun 2009, 77:2193-2200.
47. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect Immun 1998, 66(6):2460-2465.
48. Young J.C., Agashe V.R., Siegers K., Hartl F.U. Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 2004, 5:781-791.
49. Mayer M.P., Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 2005, 62:670-684.
50. Bente M., Harder S., Wiesgigl M., et al. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 2003, 3:1811-1829.
51. Louw C.A., Ludewig M.H., Mayer J., Blatch G.L. The Hsp70 chaperones of the Tritryps are characterized by unusual features and novel members. Parasitol Int 2010, 59:497-505.
52. Giambiagi-de Marval M., Souto-Padron T., Rondinelli E. Characterization and cellular distribution of Heat shock proteins HSP70 and HSP60 in Trypanosoma cruzi. Exp Parasitol 1996, 83:335-345.
53. Marañón C., Planelles L., Alonso C., López M.C. HSP70 from Trypanosoma cruzi is endowed with specif cell proliferation potential leading to apoptosis. Int Immunol 2000, 12:1685-1693.